92 related articles for article (PubMed ID: 2867105)
1. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory.
Knight J; Laing P; Knight A; Adams D; Ling N
J Clin Endocrinol Metab; 1986 Feb; 62(2):342-7. PubMed ID: 2867105
[TBL] [Abstract][Full Text] [Related]
2. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity.
Zakarija M
Horm Res; 1980; 13(1):1-15. PubMed ID: 6777285
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity.
Zakarija M
J Clin Lab Immunol; 1983 Feb; 10(2):77-85. PubMed ID: 6133001
[TBL] [Abstract][Full Text] [Related]
4. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
Knight A; Adams DD
Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
[TBL] [Abstract][Full Text] [Related]
5. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
[TBL] [Abstract][Full Text] [Related]
7. Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms.
Williams RC; Marshall NJ; Kilpatrick K; Montano J; Brickell PM; Goodall M; Ealey PA; Shine B; Weetman AP; Craig RK
J Clin Invest; 1988 Oct; 82(4):1306-12. PubMed ID: 2902107
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a monoclonal human thyroid peroxidase autoantibody of lambda light chain type.
Prummel MF; Portolano S; Costante G; Rapoport B; McLachlan SM
Mol Cell Endocrinol; 1994 Jun; 102(1-2):161-6. PubMed ID: 7926268
[TBL] [Abstract][Full Text] [Related]
9. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
10. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol.
Kasagi K; Konishi J; Arai K; Misaki T; Iida Y; Endo K; Torizuka K
J Clin Endocrinol Metab; 1986 May; 62(5):855-62. PubMed ID: 2870075
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
12. [Variable-regions of immunoglobulin H-chain genes encoding anti-TSH receptor antibodies].
Matsuda F
Nihon Rinsho; 1994 Apr; 52(4):1013-7. PubMed ID: 7910858
[TBL] [Abstract][Full Text] [Related]
13. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
[TBL] [Abstract][Full Text] [Related]
14. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses.
Weetman AP; Yateman ME; Ealey PA; Black CM; Reimer CB; Williams RC; Shine B; Marshall NJ
J Clin Invest; 1990 Sep; 86(3):723-7. PubMed ID: 2168443
[TBL] [Abstract][Full Text] [Related]
15. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.
Ochi Y; Kajita Y; Hachiya T; Hamaoki M
Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of thyroid stimulating activity within H chain fragments of TSAb-IgG by protease digestion and reduction.
Kouki T; Inui T; Hachiya T; Okabe H; Ochi Y; Kajita Y
Clin Endocrinol (Oxf); 1997 Feb; 46(2):183-8. PubMed ID: 9135700
[TBL] [Abstract][Full Text] [Related]
18. Clonal relationships between thyroid-stimulating hormone receptor-stimulating antibodies illustrate the effect of hypermutation on antibody function.
Padoa CJ; Larsen SL; Hampe CS; Gilbert JA; Dagdan E; Hegedus L; Dunn-Walters D; Banga JP
Immunology; 2010 Feb; 129(2):300-8. PubMed ID: 19845794
[TBL] [Abstract][Full Text] [Related]
19. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
20. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
Li J; Gao H; Jin SX
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
